Endocrinology and Metabolism10.3803/enm.2021.115120213651078-1085Clinicopathological Characteristics and Disease-Free Survival in Patients with Hürthle Cell Carcinoma: A Multicenter Cohort Study in South KoreaMeihua Jin, Eun Sook Kim, Bo Hyun Kim, Hee Kyung Kim, Yea Eun Kang, Min Ji Jeon, Tae Yong Kim, Ho-Cheol Kang, Won Bae Kim, Young Kee Shong, Mijin Kim, Won Gu Kim,,
BMC Cancer10.1186/1471-2407-14-7772014141Prognostic factors for disease-specific survival in 108 patients with Hürthle cell thyroid carcinoma: a single-institution experienceRok Petric, Barbara Gazic, Nikola Besic,,,
Human Pathology10.1053/j.humpath.2004.06.0112004Renal cell carcinoma in South Korea: A multicenter study*1H KIM,
Scientific Reports10.1038/s41598-020-67388-62020101Clinicopathological characteristics and survival in colorectal signet ring cell carcinoma: a population-based studyLuo-luo Yang, Min Wang, Ping He,,
Allergy, Asthma & Respiratory Disease10.4168/aard.2021.9.3.136202193136Epidemiological and clinical characteristics of 5,628 patients with coronavirus disease 2019 in South Korea: A nationwide multicenter studySeung Won Lee, Sung Yong Moon, Dong Keon Yon,,
10.21203/ Characteristics, Survival Outcomes and Prognostic Factors in Pleomorphic Carcinoma: A SEER Population-based StudyZhongzhong Chen, Jiachang Liu, Lingfeng Min,
World Journal of Surgery10.1007/s00268-017-3880-320174151395-1395Clinicopathological Characteristics and Prognostic Factors of Patients with Siewert Type II Esophagogastric Junction Carcinoma: A Retrospective Multicenter Study: ReplyTatsuo Matsuda, Hiroya Takeuchi,,
Digestive and Liver Disease10.1016/s1590-8658(20)30846-x202052S157T06.01.1 COMPARISON OF PROGNOSTIC MODELS IN PREDICTING SURVIVAL OF PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA UNDERGOING SORAFENIB TREATMENT: A MULTICENTER COHORT STUDYG. Marasco, A. Colecchia, M.L. Bacchi Reggiani, E. Dajti, F. Ravaioli, F. Avanzato, F. Trevisani, D. Festi,
Digestive and Liver Disease10.1016/j.dld.2019.12.049202052e50Comparison of prognostic models in predicting survival of patients with advanced hepatocellular carcinoma undergoing sorafenib treatment: a multicenter cohort studyG. Marasco, A. Colecchia, M.L. Bacchi Reggiani, E. Dajiti, F. Ravaioli, F. Avanzato, F. Trevisani, D. Festi,
European Journal of Surgical Oncology (EJSO)10.1016/j.ejso.2014.08.46120144011S179473. Prognostic factors for disease-specific survival in 109 patients with Hürthle cell thyroid carcinoma: A single-institution experienceI. Edhemovic, R. Petric, B. Gazic, N. Besic,